PCOS fertility boost? supplement myo-inositol tested in major trial

NCT ID NCT03059173

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether adding myo-inositol (a natural supplement) to standard clomiphene citrate treatment helps women with polycystic ovary syndrome (PCOS) ovulate more successfully. 276 women who want to become pregnant will be randomly assigned to receive either the supplement or a placebo, alongside their fertility medication. The goal is to see if the supplement reduces the number of women who do not ovulate at all during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
myo-inositol and levomefolic acid (dietary supplement) plus clomiphene citrate (drug)
What this could lead to
If it works, this could offer a simple, low-cost supplement to help women with PCOS ovulate and become pregnant with fewer failed cycles.
What could go wrong
This is a phase 3 trial, but the supplement may not improve ovulation rates. Results may not apply to all PCOS patients, and side effects from clomiphene citrate are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Lille hôpital Jeanne de Flandre

    RECRUITING

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.